Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 22;25(1):51.
doi: 10.1186/s12884-025-07175-1.

The role of 1-Deoxysphingolipids and Polyamines in the pathogenesis of placental syndrome

Affiliations

The role of 1-Deoxysphingolipids and Polyamines in the pathogenesis of placental syndrome

Filiz Yarsilikal Guleroglu et al. BMC Pregnancy Childbirth. .

Abstract

Background: Placental syndrome, mainly composed of preeclampsia and fetal growth restriction, has an impact on the health of mother and baby dyads. While impaired placentation is central to their pathophysiology, the underlying molecular mechanisms remain incompletely understood. This study investigates the association between placental syndrome and metabolic alterations in 1-deoxysphingolipids (1-deoxySLs) and polyamines, along with their regulatory enzymes.

Methods: This prospective case-control study involved 26 healthy pregnant women and 17 with placental syndrome. Blood samples were collected from maternal, uterine venous, and umbilical cord veins. Levels of 1-deoxySL, spermine, and spermidine, as well as related enzymes of polyamine metabolism such as ornithine decarboxylase (ODC), spermidine/spermine N1-acetyltransferase (SSAT), polyamine oxidase (PAO), and spermine oxidase (SMO), were measured using the techniques of LC-MS and ELISA, respectively.

Results: Women with placental syndrome had significantly higher levels of 1-deoxySL, spermine, and spermidine in all blood samples compared to the healthy pregnancy group. Additionally, ODC and SSAT levels were reduced significantly in the placental syndrome group, while PAO and SMO levels showed no significant differences. Strong positive correlations were found between the studied enzymes and biomolecules in healthy pregnancies, which were notably weaker in the placental syndrome group.

Conclusion: This study demonstrates significantly altered levels of 1-deoxySL and polyamines, with corresponding enzyme activity changes, in placental syndrome compared to healthy pregnancies. The disrupted correlations between these biomolecules suggest alterations in their metabolic pathways and potential utility as biomarkers. Further mechanistic studies are warranted to elucidate their role in placental syndrome pathophysiology.

Keywords: 1-deoxysphingolipids; Fetal growth restriction; Placental syndrome; Polyamines; Preeclampsia.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethical Committee of the Haseki Training and Research Hospital. In addition, before conducting the surveys, the informed consent was obtained from all study participants by the researchers. Disclosure statement: During the preparation of this work, the authors used AI-assisted technologies (QuillBot AI) in order to improve readability and language. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests. Clinical trial number: Not applicable.

Figures

Fig. 1
Fig. 1
Heatmap graphs of correlation coefficients of ODC, SSAT, PAO, and SMO and 1-deoxySL, spermine, and spermidine levels in all blood samples of healthy pregnancy and placental syndrome groups. Maternal, uterine venous, and umbilical cord blood samples were pooled to analyze the relationship between enzyme levels using the Pearson correlation test. ODC, Ornithine Decarboxylase; SSAT, Spermidine/Spermine N1-acetyltransferase; PAO, Polyamine Oxidase; SMO, Spermine Oxidase; and 1-deoxySL, 1-deoxysphingolipids

Similar articles

Cited by

References

    1. Stevens D, Schiffer V, Severens-Rijvers C, de Nobrega Teixeira J, van Haren A, Spaanderman M, et al. The association between decidual vasculopathy and abnormal uterine artery Doppler measurement. Acta Obstet Gynecol Scand. 2022;101(8):910–6. - PMC - PubMed
    1. ACOG. Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237–60. - PubMed
    1. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003;22(2):143–8. - PubMed
    1. Bartsch E, Medcalf KE, Park AL, Ray JG. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753. - PMC - PubMed
    1. Guo F, Zhang B, Yang H, Fu Y, Wang Y, Huang J, et al. Systemic transcriptome comparison between early- and late-onset pre-eclampsia shows distinct pathology and novel biomarkers. Cell Prolif. 2021;54(2):e12968. - PMC - PubMed

LinkOut - more resources